Dis-Chem Pharmacies Limited

JSE:DCP Stock Report

Market Cap: R31.6b

Dis-Chem Pharmacies Future Growth

Future criteria checks 4/6

Dis-Chem Pharmacies is forecast to grow earnings and revenue by 20% and 11.4% per annum respectively. EPS is expected to grow by 19.6% per annum. Return on equity is forecast to be 25.4% in 3 years.

Key information

20.0%

Earnings growth rate

19.6%

EPS growth rate

Consumer Retailing earnings growth16.5%
Revenue growth rate11.4%
Future return on equity25.4%
Analyst coverage

Good

Last updated18 Dec 2024

Recent future growth updates

Recent updates

Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?

Nov 27
Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?

Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value

Nov 10
Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value

These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Aug 21
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Jun 06
Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30
Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07
If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Aug 16
Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Jul 31
Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

May 09
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29
There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04
Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04
Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01
We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04
Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21
A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08
Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25
The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23
Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08
Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13
I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09
Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Earnings and Revenue Growth Forecasts

JSE:DCP - Analysts future estimates and past financials data (ZAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
2/28/202750,2411,7461,3283,2986
2/28/202644,9001,4931,0422,8556
2/28/202539,9261,2091,6002,9186
8/31/202437,9901,0618431,921N/A
5/31/202437,1371,0238531,906N/A
2/29/202436,2839848631,890N/A
11/30/202335,2379428691,722N/A
8/31/202334,1918998761,555N/A
5/31/202333,4279495531,437N/A
2/28/202332,6641,0002301,320N/A
11/30/202232,2311,0204401,446N/A
8/31/202231,7981,0406501,572N/A
5/31/202231,1029461,0541,704N/A
2/28/202230,4078531,4591,836N/A
11/30/202129,4078151,6381,985N/A
8/31/202128,4077761,8172,134N/A
5/31/202127,3437221,2891,649N/A
2/28/202126,2786697621,164N/A
11/30/202025,6116558221,212N/A
8/31/202024,9446418821,260N/A
5/31/202024,4646201,0211,392N/A
2/29/202023,9845981,1601,523N/A
11/30/201923,3945737501,157N/A
8/31/201922,803549339792N/A
5/31/201922,111634416839N/A
2/28/201921,420719493887N/A
11/30/201820,898718542918N/A
8/31/201820,376718591948N/A
5/31/201819,928701N/A765N/A
2/28/201819,480684N/A581N/A
11/30/201718,919715N/A910N/A
8/31/201718,359746N/A1,239N/A
5/31/201717,814679N/A1,154N/A
2/28/201717,268612N/A1,069N/A
11/30/201616,794548N/A628N/A
8/31/201616,320484N/A187N/A
5/31/201615,691498N/A278N/A
2/29/201615,061513N/A369N/A
2/28/201512,911434N/A-22N/A
2/28/201410,321409N/A455N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DCP's forecast earnings growth (20% per year) is above the savings rate (9.7%).

Earnings vs Market: DCP's earnings (20% per year) are forecast to grow faster than the ZA market (19.7% per year).

High Growth Earnings: DCP's earnings are forecast to grow, but not significantly.

Revenue vs Market: DCP's revenue (11.4% per year) is forecast to grow faster than the ZA market (3.8% per year).

High Growth Revenue: DCP's revenue (11.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DCP's Return on Equity is forecast to be high in 3 years time (25.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 18:06
End of Day Share Price 2025/01/10 00:00
Earnings2024/08/31
Annual Earnings2024/02/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dis-Chem Pharmacies Limited is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel DiasArqaam Capital Research Offshore S.A.L.
Michael de NobregaAvior Capital Markets
Paul Henri SteegersBofA Global Research